Structure Therapeutics Inc. (GPCR) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value |
| Current obligations | 66.11M USD | Liabilities, Current |
| Cash and equivalents | 272.64M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $66.11M | $272.64M | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $56.98M | $316.17M | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $63.28M | $799.62M | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $57.53M | $102.91M | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $39.03M | $147.02M | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $36.49M | $152.12M | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $36.02M | $169.51M | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $33.43M | $172.13M | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $22.66M | $381.63M | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $23.59M | $97.83M | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $24.74M | $129.79M | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $20.09M | $50.64M | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $15.01M | $40.59M | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $11.00M | $126.49M | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $13.01M | $26.09M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |